emodin and sorafenib
emodin has been researched along with sorafenib in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Kan, SY; Kang, H; Kim, BM; Kim, GH; Kim, JH; Kim, YS; Lee, YM; Lim, JH; Oh, TI; Shin, DH; Yim, WJ | 1 |
Other Studies
1 other study(ies) available for emodin and sorafenib
| Article | Year |
|---|---|
Emodin Sensitizes Hepatocellular Carcinoma Cells to the Anti-Cancer Effect of Sorafenib through Suppression of Cholesterol Metabolism.
Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cholesterol; Drug Synergism; Emodin; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Liver Neoplasms; Mice; Proto-Oncogene Proteins c-akt; Signal Transduction; Sorafenib; Sterol Regulatory Element Binding Protein 2; Xenograft Model Antitumor Assays | 2018 |